These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30974104)

  • 1. A 3D bioprinted hydrogel mesh loaded with all-trans retinoic acid for treatment of glioblastoma.
    Mirani B; Pagan E; Shojaei S; Duchscherer J; Toyota BD; Ghavami S; Akbari M
    Eur J Pharmacol; 2019 Jul; 854():201-212. PubMed ID: 30974104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction Therapy of Retinoic Acid with a Temozolomide-Loaded Gold Nanoparticle-Associated Ultrasound Effect on Glioblastoma Cancer Stem-Like Colonies.
    Fadera S; Chen PY; Liu HL; Lee IC
    ACS Appl Mater Interfaces; 2021 Jul; 13(28):32845-32855. PubMed ID: 34235925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. All-trans retinoic acid eluting poly(diol citrate) wafers for treatment of glioblastoma.
    Jones T; Zhang B; Major S; Webb A
    J Biomed Mater Res B Appl Biomater; 2020 Apr; 108(3):619-628. PubMed ID: 31087625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vitro Glioblastoma Model on a Plate for Localized Drug Release Study from a 3D-Printed Drug-Eluted Hydrogel Mesh.
    Chehri B; Liu K; Vaseghi G; Seyfoori A; Akbari M
    Cells; 2024 Feb; 13(4):. PubMed ID: 38391976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quinacrine Mediated Sensitization of Glioblastoma (GBM) Cells to TRAIL through MMP-Sensitive PEG Hydrogel Carriers.
    Erkoc P; Cingöz A; Onder TB; Kizilel S
    Macromol Biosci; 2017 Feb; 17(2):. PubMed ID: 27762493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temozolomide-loaded photopolymerizable PEG-DMA-based hydrogel for the treatment of glioblastoma.
    Fourniols T; Randolph LD; Staub A; Vanvarenberg K; Leprince JG; Préat V; des Rieux A; Danhier F
    J Control Release; 2015 Jul; 210():95-104. PubMed ID: 25982679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting cancer stem cells in glioblastoma multiforme using mTOR inhibitors and the differentiating agent all-trans retinoic acid.
    Friedman MD; Jeevan DS; Tobias M; Murali R; Jhanwar-Uniyal M
    Oncol Rep; 2013 Oct; 30(4):1645-50. PubMed ID: 23877261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. All-trans retinoic acid modulates cancer stem cells of glioblastoma multiforme in an MAPK-dependent manner.
    Karsy M; Albert L; Tobias ME; Murali R; Jhanwar-Uniyal M
    Anticancer Res; 2010 Dec; 30(12):4915-20. PubMed ID: 21187470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced targeting of invasive glioblastoma cells by peptide-functionalized gold nanorods in hydrogel-based 3D cultures.
    Gonçalves DPN; Rodriguez RD; Kurth T; Bray LJ; Binner M; Jungnickel C; Gür FN; Poser SW; Schmidt TL; Zahn DRT; Androutsellis-Theotokis A; Schlierf M; Werner C
    Acta Biomater; 2017 Aug; 58():12-25. PubMed ID: 28576716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioengineered 3D brain tumor model to elucidate the effects of matrix stiffness on glioblastoma cell behavior using PEG-based hydrogels.
    Wang C; Tong X; Yang F
    Mol Pharm; 2014 Jul; 11(7):2115-25. PubMed ID: 24712441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-resection treatment of glioblastoma with an injectable nanomedicine-loaded photopolymerizable hydrogel induces long-term survival.
    Zhao M; Danhier F; Bastiancich C; Joudiou N; Ganipineni LP; Tsakiris N; Gallez B; Rieux AD; Jankovski A; Bianco J; Préat V
    Int J Pharm; 2018 Sep; 548(1):522-529. PubMed ID: 30017818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temperature and pH-responsive in situ hydrogels of gelatin derivatives to prevent the reoccurrence of brain tumor.
    Kang JH; Turabee MH; Lee DS; Kwon YJ; Ko YT
    Biomed Pharmacother; 2021 Nov; 143():112144. PubMed ID: 34509823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioprinting of glioma stem cells improves their endotheliogenic potential.
    Wang X; Li X; Dai X; Zhang X; Zhang J; Xu T; Lan Q
    Colloids Surf B Biointerfaces; 2018 Nov; 171():629-637. PubMed ID: 30107336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of all-trans retinoic acid and interferon-gamma upregulated p27(kip1) and down regulated CDK2 to cause cell cycle arrest leading to differentiation and apoptosis in human glioblastoma LN18 (PTEN-proficient) and U87MG (PTEN-deficient) cells.
    Zhang R; Banik NL; Ray SK
    Cancer Chemother Pharmacol; 2008 Aug; 62(3):407-16. PubMed ID: 17960384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of all-trans retinoic acid and interferon-gamma suppressed PI3K/Akt survival pathway in glioblastoma T98G cells whereas NF-kappaB survival signaling in glioblastoma U87MG cells for induction of apoptosis.
    Zhang R; Banik NL; Ray SK
    Neurochem Res; 2007 Dec; 32(12):2194-202. PubMed ID: 17616812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-302b-inhibited E2F3 transcription factor is related to all trans retinoic acid-induced glioma cell apoptosis.
    Chen PH; Shih CM; Chang WC; Cheng CH; Lin CW; Ho KH; Su PC; Chen KC
    J Neurochem; 2014 Dec; 131(6):731-42. PubMed ID: 25040912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticancer drug-loaded hydrogels as drug delivery systems for the local treatment of glioblastoma.
    Bastiancich C; Danhier P; Préat V; Danhier F
    J Control Release; 2016 Dec; 243():29-42. PubMed ID: 27693428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D bioprinted glioma stem cells for brain tumor model and applications of drug susceptibility.
    Dai X; Ma C; Lan Q; Xu T
    Biofabrication; 2016 Oct; 8(4):045005. PubMed ID: 27725343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3D bioprinting of urethra with PCL/PLCL blend and dual autologous cells in fibrin hydrogel: An in vitro evaluation of biomimetic mechanical property and cell growth environment.
    Zhang K; Fu Q; Yoo J; Chen X; Chandra P; Mo X; Song L; Atala A; Zhao W
    Acta Biomater; 2017 Mar; 50():154-164. PubMed ID: 27940192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel RGD containing, temozolomide-loading nanostructured lipid carriers for glioblastoma multiforme chemotherapy.
    Song S; Mao G; Du J; Zhu X
    Drug Deliv; 2016 May; 23(4):1404-8. PubMed ID: 26203687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.